Selected research
Industry Research
Iridoids Industry Research Report 2026
Market perspective
The global Iridoids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Iridoids is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Iridoids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Iridoids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Iridoids include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Iridoids market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Iridoids.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Iridoids Market by Company
Wuhan Chengyuan Pharmaceutical Co
Shaanxi Sciphar Hi-Tech
Lunan Pharmaceutical Group
Kemin Industries
Sigma-Aldrich
Nexira
Martin Bauer Group
LKT Labs
Layn Natural Ingredients
Indena
Enzo Life Sciences
Dalian Sky Chemical
Iridoids Segment by Type
Natural
Synthesis
Iridoids Segment by Application
Drugs
Health Products
Others
Iridoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iridoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iridoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iridoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Iridoids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Iridoids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Iridoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural
- Synthesis
Applications
- Drugs
- Health Products
- Others
Companies covered
- Wuhan Chengyuan Pharmaceutical Co
- Shaanxi Sciphar Hi-Tech
- Lunan Pharmaceutical Group
- Kemin Industries
- Sigma-Aldrich
- Nexira
- Martin Bauer Group
- LKT Labs
- Layn Natural Ingredients
- Indena
- Enzo Life Sciences
- Dalian Sky Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Iridoids by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Natural
- 2.2.3 Synthesis
- 2.3 Iridoids by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Drugs
- 2.3.3 Health Products
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Iridoids Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Iridoids Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Iridoids Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Iridoids Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Iridoids Production by Manufacturers (2021-2026)
- 3.2 Global Iridoids Production Value by Manufacturers (2021-2026)
- 3.3 Global Iridoids Average Price by Manufacturers (2021-2026)
- 3.4 Global Iridoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iridoids Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Iridoids Manufacturers, Product Type & Application
- 3.7 Global Iridoids Manufacturers Established Date
- 3.8 Global Iridoids Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Chengyuan Pharmaceutical Co
- 4.1.1 Wuhan Chengyuan Pharmaceutical Co Iridoids Company Information
- 4.1.2 Wuhan Chengyuan Pharmaceutical Co Iridoids Business Overview
- 4.1.3 Wuhan Chengyuan Pharmaceutical Co Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Wuhan Chengyuan Pharmaceutical Co Product Portfolio
- 4.1.5 Wuhan Chengyuan Pharmaceutical Co Recent Developments
- 4.2 Shaanxi Sciphar Hi-Tech
- 4.2.1 Shaanxi Sciphar Hi-Tech Iridoids Company Information
- 4.2.2 Shaanxi Sciphar Hi-Tech Iridoids Business Overview
- 4.2.3 Shaanxi Sciphar Hi-Tech Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Shaanxi Sciphar Hi-Tech Product Portfolio
- 4.2.5 Shaanxi Sciphar Hi-Tech Recent Developments
- 4.3 Lunan Pharmaceutical Group
- 4.3.1 Lunan Pharmaceutical Group Iridoids Company Information
- 4.3.2 Lunan Pharmaceutical Group Iridoids Business Overview
- 4.3.3 Lunan Pharmaceutical Group Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Lunan Pharmaceutical Group Product Portfolio
- 4.3.5 Lunan Pharmaceutical Group Recent Developments
- 4.4 Kemin Industries
- 4.4.1 Kemin Industries Iridoids Company Information
- 4.4.2 Kemin Industries Iridoids Business Overview
- 4.4.3 Kemin Industries Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Kemin Industries Product Portfolio
- 4.4.5 Kemin Industries Recent Developments
- 4.5 Sigma-Aldrich
- 4.5.1 Sigma-Aldrich Iridoids Company Information
- 4.5.2 Sigma-Aldrich Iridoids Business Overview
- 4.5.3 Sigma-Aldrich Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Sigma-Aldrich Product Portfolio
- 4.5.5 Sigma-Aldrich Recent Developments
- 4.6 Nexira
- 4.6.1 Nexira Iridoids Company Information
- 4.6.2 Nexira Iridoids Business Overview
- 4.6.3 Nexira Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Nexira Product Portfolio
- 4.6.5 Nexira Recent Developments
- 4.7 Martin Bauer Group
- 4.7.1 Martin Bauer Group Iridoids Company Information
- 4.7.2 Martin Bauer Group Iridoids Business Overview
- 4.7.3 Martin Bauer Group Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Martin Bauer Group Product Portfolio
- 4.7.5 Martin Bauer Group Recent Developments
- 4.8 LKT Labs
- 4.8.1 LKT Labs Iridoids Company Information
- 4.8.2 LKT Labs Iridoids Business Overview
- 4.8.3 LKT Labs Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 LKT Labs Product Portfolio
- 4.8.5 LKT Labs Recent Developments
- 4.9 Layn Natural Ingredients
- 4.9.1 Layn Natural Ingredients Iridoids Company Information
- 4.9.2 Layn Natural Ingredients Iridoids Business Overview
- 4.9.3 Layn Natural Ingredients Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Layn Natural Ingredients Product Portfolio
- 4.9.5 Layn Natural Ingredients Recent Developments
- 4.10 Indena
- 4.10.1 Indena Iridoids Company Information
- 4.10.2 Indena Iridoids Business Overview
- 4.10.3 Indena Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Indena Product Portfolio
- 4.10.5 Indena Recent Developments
- 4.11 Enzo Life Sciences
- 4.11.1 Enzo Life Sciences Iridoids Company Information
- 4.11.2 Enzo Life Sciences Iridoids Business Overview
- 4.11.3 Enzo Life Sciences Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Enzo Life Sciences Product Portfolio
- 4.11.5 Enzo Life Sciences Recent Developments
- 4.12 Dalian Sky Chemical
- 4.12.1 Dalian Sky Chemical Iridoids Company Information
- 4.12.2 Dalian Sky Chemical Iridoids Business Overview
- 4.12.3 Dalian Sky Chemical Iridoids Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Dalian Sky Chemical Product Portfolio
- 4.12.5 Dalian Sky Chemical Recent Developments
5 Global Iridoids Production by Region
- 5.1 Global Iridoids Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Iridoids Production by Region: 2021-2032
- 5.2.1 Global Iridoids Production by Region: 2021-2026
- 5.2.2 Global Iridoids Production Forecast by Region (2027-2032)
- 5.3 Global Iridoids Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Iridoids Production Value by Region: 2021-2032
- 5.4.1 Global Iridoids Production Value by Region: 2021-2026
- 5.4.2 Global Iridoids Production Value Forecast by Region (2027-2032)
- 5.5 Global Iridoids Market Price Analysis by Region (2021-2026)
- 5.6 Global Iridoids Production and Value, YOY Growth
- 5.6.1 North America Iridoids Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Iridoids Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Iridoids Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Iridoids Production Value Estimates and Forecasts (2021-2032)
6 Global Iridoids Consumption by Region
- 6.1 Global Iridoids Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iridoids Consumption by Region (2021-2032)
- 6.2.1 Global Iridoids Consumption by Region: 2021-2026
- 6.2.2 Global Iridoids Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Iridoids Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Iridoids Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Iridoids Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Iridoids Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Iridoids Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Iridoids Production by Type (2021-2032)
- 7.1.1 Global Iridoids Production by Type (2021-2032) & (t)
- 7.1.2 Global Iridoids Production Market Share by Type (2021-2032)
- 7.2 Global Iridoids Production Value by Type (2021-2032)
- 7.2.1 Global Iridoids Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Iridoids Production Value Market Share by Type (2021-2032)
- 7.3 Global Iridoids Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Iridoids Production by Application (2021-2032)
- 8.1.1 Global Iridoids Production by Application (2021-2032) & (t)
- 8.1.2 Global Iridoids Production Market Share by Application (2021-2032)
- 8.2 Global Iridoids Production Value by Application (2021-2032)
- 8.2.1 Global Iridoids Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Iridoids Production Value Market Share by Application (2021-2032)
- 8.3 Global Iridoids Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Iridoids Value Chain Analysis
- 9.1.1 Iridoids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Iridoids Production Mode & Process
- 9.2 Iridoids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iridoids Distributors
- 9.2.3 Iridoids Customers
10 Global Iridoids Analyzing Market Dynamics
- 10.1 Iridoids Industry Trends
- 10.2 Iridoids Industry Drivers
- 10.3 Iridoids Industry Opportunities and Challenges
- 10.4 Iridoids Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst